Fairmount Funds Management LLC
An institutional investment manager in WEST CONSHOHOCKEN, PA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1802528.
- Reported value$1.51bn
- Positions12
Holdings: 12 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Oruka Therapeutics IncORKA | COM | 687604108 | 353 | 23.3% | 3,705,262 | Unchanged | |
| Dianthus Therapeutics IncDNTH | COM | 252828108 | 247 | 16.3% | 2,537,191 | Unchanged | |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 227 | 15.0% | 8,713,000 | Unchanged | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 213 | 14.1% | 5,503,418 | Unchanged | |
| Jade Biosciences IncJBIO | COM NEW | 008064206 | 101 | 6.7% | 4,553,494 | Unchanged | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 94.2 | 6.2% | 1,855,644 | Unchanged | |
| Viridian Therapeutics IncVRDN | COM | 92790C104 | 93.5 | 6.2% | 5,090,928 | Added+1,176,470 | |
| Zenas Biopharma IncZBIO | COM | 98937L105 | 59.9 | 4.0% | 2,359,025 | Unchanged | |
| Crescent Biopharma Inc. | COM | G2545C104 | 49.5 | 3.3% | 2,747,866 | Unchanged | |
| Apogee Therapeutics Inc | COM | 03770N101 | 39.6 | 2.6% | 298,647 | Unchanged | |
| Faeth Therapeutics IncFTH | COM NEW | 81728A207 | 18.1 | 1.2% | 722,020 | New+722,020 | |
| Inhibikase Therapeutics IncIKT | COM NEW | 45719W205 | 17.5 | 1.2% | 8,625,000 | Unchanged |
Sold out: 1 position
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 0.0 | 0.0% | 0 | Sold out−4,018,101 |
Source: SEC EDGAR, Form 13F-HR, accession 0001104659-26-096405 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.